Holen Sie sich die Stockscreener-App
97.71
1.53%
1.47
Handel nachbörslich:
97.97
0.26
+0.27%
Schlusskurs vom Vortag:
$96.24
Offen:
$95.93
24-Stunden-Volumen:
9.16M
Relative Volume:
1.10
Marktkapitalisierung:
$144.78B
Einnahmen:
$18.49B
Nettoeinkommen (Verlust:
$2.50B
KGV:
58.16
EPS:
1.6801
Netto-Cashflow:
$3.49B
1W Leistung:
+0.95%
1M Leistung:
-2.16%
6M Leistung:
+3.69%
1J Leistung:
+12.61%
1-Tages-Spanne:
$95.59
$99.61
1-Wochen-Bereich:
$94.53
$99.61
52-Wochen-Spanne:
$80.64
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
97.71 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
ABT
Abbott Laboratories
|
129.45 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
SYK
Stryker Corp
|
369.75 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.34 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.93 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
What Fibonacci levels say about Boston Scientific Corporation rebound2025 Market Outlook & Proven Capital Preservation Tips - newser.com
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Why Boston Scientific Corporation stock remains on watchlistsJuly 2025 News Drivers & AI Powered Market Entry Ideas - newser.com
What Makes Boston Scientific Corporation (BSX) an Investment Choice? - Yahoo Finance
Is Boston Scientific’s Share Price Justified After Its Recent 7.6% Monthly Drop in 2025? - Yahoo Finance
OFI Invest Asset Management Has $1.38 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
What You Need To Know Ahead of Boston Scientific's Earnings Release - MSN
Aberdeen Group plc Trims Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Stock Moves -1.92%: What You Should Know - Yahoo Finance
Boston Scientific stock rating reiterated at Buy by TD Cowen - Investing.com
Is Boston Scientific Corporation stock a safe buy pre earningsQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
November 28th Options Now Available For Boston Scientific (BSX) - Nasdaq
Real time alert setup for Boston Scientific Corporation performance2025 Market WrapUp & AI Based Buy and Sell Signals - newser.com
How to forecast Boston Scientific Corporation trends using time series2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
Bank of America Securities Remains a Buy on Boston Scientific (BSX) - The Globe and Mail
Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings - Seeking Alpha
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth - Investing.com
Shell Asset Management Co. Increases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability - Markets Mojo
Evercore ISI Revises Boston Scientific (BSX) Price Target to $11 - GuruFocus
Boston Scientific (BSX) Target Price Cut by Evercore ISI Amid Ma - GuruFocus
Boston Scientific (BSX): Evaluating Valuation as Analyst Confidence Remains High Following Strong Segment Growth and Innovation - simplywall.st
What You Need To Know Ahead Of Boston Scientific's Earnings Release - Barchart.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Using data tools to time your Boston Scientific Corporation exitMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Cullinan Associates Inc. Sells 13,300 Shares of Boston Scientific Corporation $BSX - MarketBeat
Knights of Columbus Asset Advisors LLC Purchases 5,188 Shares of Boston Scientific Corporation $BSX - MarketBeat
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $125 to $136 - 富途牛牛
QRG Capital Management Inc. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific’s Innovation Push in Endoscopy at MEDevice Boston a Sign of R&D Leadership (BSX)? - Yahoo Finance
Penobscot Investment Management Company Inc. Buys 10,177 Shares of Boston Scientific Corporation $BSX - MarketBeat
Jackson Wealth Management LLC Has $4.91 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Raises Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Mirae Asset Global Investments Co. Ltd. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Truist Financial Corp Sells 18,116 Shares of Boston Scientific Corporation $BSX - MarketBeat
Sava Infond d.o.o. Has $5.79 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
How Are Analysts Weighing Boston Scientific’s (BSX) Innovation Pipeline Against Market Execution Strategies? - simplywall.st
Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX) - Yahoo Finance
Boston Scientific stock rating reiterated at Overweight by Piper Sandler - Investing.com
FY2027 EPS Estimate for Boston Scientific Boosted by Analyst - MarketBeat
The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco - sharewise.com
Boston Scientific stock rating downgraded to Hold by Erste Group - Investing.com
RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT - Insider Monkey
Consolidated Portfolio Review Corp Acquires Shares of 3,136 Boston Scientific Corporation $BSX - MarketBeat
How Boston Scientific Corporation stock benefits from digital adoptionEarnings Risk Report & Detailed Earnings Play Alerts - newser.com
Top Research Reports for Boston Scientific, Union Pacific & Realty Income - Yahoo Finance
Oppenheimer Sticks to Their Buy Rating for Boston Scientific (BSX) - The Globe and Mail
Leerink Partners Reaffirms Their Buy Rating on Boston Scientific (BSX) - The Globe and Mail
Truist Financial Sticks to Their Buy Rating for Boston Scientific (BSX) - The Globe and Mail
27,070 Shares in Boston Scientific Corporation $BSX Bought by Lecap Asset Management Ltd. - MarketBeat
Boston Scientific aims for market leadership in electrophysiology - Yahoo Finance
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):